Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2005 3
2006 8
2007 2
2008 7
2009 5
2010 5
2011 9
2012 6
2013 3
2014 3
2015 3
2016 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Different innate signatures induced in human monocyte-derived dendritic cells by wild-type dengue 3 virus, attenuated but reactogenic dengue 3 vaccine virus, or attenuated nonreactogenic dengue 1-4 vaccine virus strains.
Balas C, Kennel A, Deauvieau F, Sodoyer R, Arnaud-Barbe N, Lang J, Guy B. Balas C, et al. Among authors: lang j. J Infect Dis. 2011 Jan 1;203(1):103-8. doi: 10.1093/infdis/jiq022. J Infect Dis. 2011. PMID: 21148502 Free PMC article. Review.
Dengue vaccine prospects: a step forward.
Guy B, Almond J, Lang J. Guy B, et al. Among authors: lang j. Lancet. 2011 Jan 29;377(9763):381-2. doi: 10.1016/S0140-6736(11)60128-1. Lancet. 2011. PMID: 21277439 No abstract available.
[Tetravalent dengue vaccine development].
Guy B, Saville M, Lang J. Guy B, et al. Among authors: lang j. Virologie (Montrouge). 2010 Oct 1;14(5):311-321. doi: 10.1684/vir.2011.15882. Virologie (Montrouge). 2010. PMID: 36151693 French.
Efficacy of a tetravalent dengue vaccine in children in Latin America.
Villar L, Dayan GH, Arredondo-García JL, Rivera DM, Cunha R, Deseda C, Reynales H, Costa MS, Morales-Ramírez JO, Carrasquilla G, Rey LC, Dietze R, Luz K, Rivas E, Miranda Montoya MC, Cortés Supelano M, Zambrano B, Langevin E, Boaz M, Tornieporth N, Saville M, Noriega F; CYD15 Study Group. Villar L, et al. N Engl J Med. 2015 Jan 8;372(2):113-23. doi: 10.1056/NEJMoa1411037. Epub 2014 Nov 3. N Engl J Med. 2015. PMID: 25365753 Free article. Clinical Trial.
Assessing the potential of a candidate dengue vaccine with mathematical modeling.
WHO-VMI Dengue Vaccine Modeling Group; Beatty M, Boni MF, Brown S, Buathong R, Burke D, Coudeville L, Cummings DA, Edelman R, Farrar J, Focks DA, Gomes MG, Guignard A, Halstead S, Hombach J, Knerer G, Koelle K, Lam FC, Lang J, Longini I, Medlock J, Namgyal P, Powell M, Recker M, Rohani P, Standaert B, Struchiner C, Teyssou R, Wearing H. WHO-VMI Dengue Vaccine Modeling Group, et al. Among authors: lang j. PLoS Negl Trop Dis. 2012;6(3):e1450. doi: 10.1371/journal.pntd.0001450. Epub 2012 Mar 27. PLoS Negl Trop Dis. 2012. PMID: 22479655 Free PMC article. No abstract available.
56 results